Pharmaceutical compositions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 2, 1999
Grant Date -
N/A
app pub date -
Sep 23, 1997
filing date -
Mar 29, 1995
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Certain 3-(Pyrimidin-4-yl)-1-phenylpyridazin-4(1H)-ones of formula I ##STR1## including pharmaceutically acceptable salts thereof; in which g is 0,1,2,3,4 or 5; R.sub.1 independently represents halo; and R.sub.2 represents H, C.sub.1-4 alkyl, C.sub.3-6 cycloalkyl or optionally substituted phenyl; have utility in the treatment of seizures and/or neurological disorders such as epilepsy and/or conditions in which there is neurological damage such as brain trauma, cerebral ischaemia, haemorrhage, head injuries and stroke.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully